Patent ID: 9587030
Date: 2017-03-07
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method of treating an autoimmune disease or condition, a systemic inflammatory disease or condition, or transplant rejection in a human subject in need thereof, the method comprising administering to the subject a therapeutically effective, or prophylactically effective, amount of an antibody or a fragment thereof that specifically binds to human OX40-ligand (hOX40L) and competes for binding to said hOX40L with the antibody 02D10 which comprises a heavy chain amino acid sequence of SEQ ID No:62 and a light chain amino acid sequence of SEQ ID No:64, the antibody or fragment thereof comprising a VH domain which comprises the HCDR3 sequence of SEQ ID NO:40 or 46.